Significant industry consolidation has occurred during the past 10 to 20 years and has more recently affected the generic drug industry. In 2014, a newly introduced medication for hepatitis C reported sales of $10.3 billion, with a full 12-week course of therapy reaching $84,000 per patient. U.S. prescription drug spending rose 13% in 2014. 11 The average price of one type of insulin has increased from $600 to $1,200 per vial in less than three years. The cost for the generic antibiotic doxycycline has risen 8,281%, asthma treatment albuterol by 4,014% and anti-cholesterol medication pravastatin by 573%. 12, 13 The Centers for Medicare & Medicaid Service (CMS) does not include hospital and specialty drugs subject to medical claims (J-codes) in gross drug spending calculations. As a result, the vast majority of healthcare professionals are Evidence-based medicine has been defined as "the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients." 23 Evidence-based healthcare broadens the concept to include an "understanding of the patients', families', and doctors' beliefs, values and attitudes" into their decision-making. 24 A significant gap exists between theory and practice, as it applies to clinical effectiveness:
• Healthcare delivery remains focused on acute intervention rather than primary, secondary, and tertiary prevention focused on preventing and minimizing the impact of diseases and conditions
• Despite the increasing focus on population health, and the availability of given year. 25 Behavioral health disorders have a significant impact on the total cost of care; i.e., those with co-morbid depression have average costs 53% higher (range: 34% to 141% depending on the specific condition) than those with a chronic condition or cancer alone due to psychosomatic and/ or treatment adherence issues. 26 The under diagnosis and treatment of behavioral health conditions is common, estimated at 60% to 80%. 27 Further quantifying waste in the healthcare system, The Commonwealth Fund estimated $226 billion for the over-utilization of healthcare services, leading to no patient benefit or even negative outcomes. 33 In its seminal report entitled "Waste and Inefficiency in the U.S. Healthcare System," the New England Healthcare
Institute identified cost savings of $100 million to $10 billion associated with inappropriate antibiotic usage for upper respiratory infections, the overuse of back-imaging studies, excessive surgery (hysterectomy, spinal, coronary) and percutaneous coronary interventions. 34 A shift from fee-for-service to valuebased reimbursement would, at least partially, remediate over-utilization of healthcare services.
Facilitating Payment Reform: Grade: B
The most important fundamental healthcare delivery issue capable of incentivizing behavior change is reimbursement. The current healthcare system is still primarily based on fee-for-service payment system that rewards volume (at the highest possible prices) and not value. This has led to an excess of diagnostic procedures, advanced imaging scans and surgical interventions as well as significant variation in the site of service and procedure costs. Fee-forservice reimbursement has also led to care fragmentation, with poor transition management from hospitals to post-acute care facilities and home.
Obamacare, through the funding of pilot programs and CMS Innovation Center initiatives focused on value-based ("integrative") payment reform, has increased provider focus on quality, the care continuum, transition management, care navigation, post-acute care, the total cost of care, and elsewhere. It has also highlighted the importance of information technology (IT) system interoperability and the role of analytics to better manage the health of populations and individual patients. Value is a function of quality and cost. Quality measurements have evolved to include structure, process, outcome, patient experience of care and access.
Evidence-based practice requires a reduction in variability toward best practices.
CMS has provided incentives to improve care processes and health outcomes, payments. We will use benchmarks and metrics to measure our progress; and hold ourselves accountable for reaching our goals. Our first goal is for 30% of all
Medicare provider payments to be in alternative payment models that are tied to how well providers care for their patients, instead of how much care they provide-and to do it by 2016. Our goal would then be to get to 50% by 2018. 
